Venous thromboembolism during primary treatment of ovarian clear cell carcinoma is associated with decreased survival

Gynecologic Oncology

Volumn 131, Issue 3, 2013, Pages 541-545

  Diaz, Elena S ^a   Walts, Ann E ^a   Karlan, Beth Y ^a   Walsh, Christine S ^a  

^a CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

Ovarian clear cell carcinoma; Survival; Venous thromboembolism

Indexed keywords

ADULT; AGED; ARTICLE; CANCER MORTALITY; CANCER SURVIVAL; CLEAR CELL CARCINOMA; FEMALE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MEDICAL RECORD; OVARY CARCINOMA; OVARY CLEAR CELL CARCINOMA; OVERALL SURVIVAL; PATHOLOGY; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; VENOUS THROMBOEMBOLISM;

OVARIAN CLEAR CELL CARCINOMA; SURVIVAL; VENOUS THROMBOEMBOLISM;

ADENOCARCINOMA, CLEAR CELL; ADULT; AGED; AGED, 80 AND OVER; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; OVARIAN NEOPLASMS; SURVIVAL RATE; VENOUS THROMBOEMBOLISM; YOUNG ADULT;

EID: 84888286234     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2013.09.005     Document Type: Article

References (21)

1. Cancer facts and figures 2013 American Cancer Society [http://www.cancer.org/acs/groups/content/@epidemiologysurveilance/documents/ document/acspc-036845.pdf]
2. M.S. Anglesio, M.S. Carey, M. KÓbel, H. MacKay, and D.G. Huntsman Vancouver Ovarian Clear Cell Symposium Speakers. Clear cell carcinoma of the ovary: a report from the first Ovarian Clear Cell Symposium, June 24th, 2010 Gynecol Oncol 121 2011 407 415
3. B.A. Goff, R. Sainz de la Cuesta, H.G. Muntz, D. Fleischhaker, M. Ek, and L.W. Rice Clear cell carcinoma of the ovary: a distinct histologic type with poor prognosis and resistance to platinum-based chemotherapy in stage III disease Gynecol Oncol 60 1996 412 417
4. T. Sugiyama, T. Kamura, J. Kigawa, N. Terakawa, Y. Kikuchi, and T. Kita Clinical characteristics of clear cell carcinoma of the ovary: a distinct histologic type with poor prognosis and resistance to platinum-based chemotherapy Cancer 88 2000 2584 2589
5. Y. Matsuura, G. Robertson, D.E. Marsden, S.N. Kim, V. Gebski, and N.F. Hacker Thromboembolic complications in patients with clear cell carcinoma of the ovary Gynecol Oncol 104 2007 406 410
6. L.R. Duska, L. Garrett, M. Henretta, J.S. Ferriss, L. Lee, and N. Horowitz When 'never-events' occur despite adherence to clinical guidelines: the case of venous thromboembolism in clear cell cancer of the ovary compared with other epithelial histologic subtypes Gynecol Oncol 116 2010 374 377
7. G.H. Eltabbakh, S.L. Mount, B. Beatty, L. Simmons-Arnold, and K. Cooper Clinical and molecular differences between clear cell and papillary serous ovarian carcinoma J Surg Oncol 93 2006 379 386
8. M.G. Del Carmen, M. Birrer, and J.O. Schorge Clear cell carcinoma of the ovary: a review of the literature Gynecol Oncol 126 3 2012 481 490
9. K. Matsuo, A.A. Yessaian, Y.G. Lin, H.Q. Pham, L.I. Muderspach, and H.A. Liebman Predictive model of venous thromboembolism in endometrial cancer Gynecol Oncol 128 3 Mar 2013 544 551
10. R. Sandhu, C.X. Pan, T. Wun, D. Harvey, H. Zhou, and R.H. White The incidence of venous thromboembolism and its effect on survival among patients with primary bladder cancer Cancer 116 11 Jun 1 2010 2596 2603
11. R.A.C. Auer, A.S. Scheer, J.I. McSparron, A.R. Schulman, S. Tuorto, and S. Doucette Postoperative venous thromboembolism predicts survival in cancer patients Ann Surg 255 5 May 2012 963 970
12. R.S. Kasthuri, M.B. Taubman, and N. Mackman Role of tissue factor in cancer J Clin Oncol 27 29 Oct 10 2009 4834-8.26
13. Y.W. van den Berg, S. Osanto, P.H. Reitsma, and H.H. Versteeg The relationship between tissue factor and cancer progression: insights from bench and bedside Blood 119 4 Jan 26 2012 924 927
14. D.A. Manly, J. Wang, S.L. Glover, R. Kasthuri, H.A. Liebman, and N.S. Key Increased microparticle tissue factor activity in cancer patients with venous thromboembolism Thromb Res 125 6 2010 511 512
15. M.E. Tesselaar, F.P. Romijn, I.K. Van Der Linden, F.A. Prins, R.M. Bertina, and S. Osanto Microparticle-associated tissue factor activity: a link between cancer and thrombosis? J Thromb Haemost 5 3 Mar 2007 520 527
16. E. Campello, L. Spiezia, C.M. Radu, C. Bulato, M. Castelli, and S. Gavasso Endothelial, platelet, and tissue factor-bearing microparticles in cancer patients with and without venous thromboembolism Thromb Res 127 5 May 2011 473 477
17. J.I. Zwicker, H.A. Liebman, D. Neuberg, R. Lacroix, K.A. Bauer, and B.C. Furie Tumor-derived tissue factor-bearing microparticles are associated with venous thromboembolic events in malignancy Clin Cancer Res 15 22 Nov 15 2009 6830 6840
18. K. Uno, S. Homma, T. Satoh, K. Nakanishi, D. Abe, and K. Matsumoto Tissue factor expression as a possible determinant of thromboembolism in ovarian cancer Br J Cancer 96 2 Jan 29 2007 290 295
19. A. Young, O. Chapman, C. Connor, C. Poole, P. Rose, and A.K. Kakkar Thrombosis and cancer Nat Rev Clin Oncol 9 8 Jul 10 2012 437 449
20. Z. Ma, T. Zhang, R. Wang, Z. Cheng, H. Xu, and W. Li Tissue factor-factor VIIa complex induces epithelial ovarian cancer cell invasion and metastasis through a monocytes-dependent mechanism Int J Gynecol Cancer 21 4 May 2011 616 624
21. L.Y. Han, C.N. Landen Jr., A.A. Kamat, A. Lopez, D.P. Bender, and P. Mueller Preoperative serum tissue factor levels are an independent prognostic factor in patients with ovarian carcinoma J Clin Oncol 24 5 Feb 10 2006 755 761